A Review of Current and Emerging Treatment Options for Myelodysplastic Syndromes

In this comprehensive program centered on an in-person and online live CCO symposium at ASH 2021 experts discuss recent developments in the management of myelodysplastic syndromes. Review their insights in an on-demand webcast and downloadable slides from the symposium.

Share

Program Content

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AbbVie Inc.

Gamida Cell Ltd

Geron

Gilead Sciences, Inc.

Karyopharm Therapeutics Inc.

Takeda Pharma USA Inc Takeda Onc Co